AnaptysBio (ANAB) PT Lowered to $93 at Piper Sandler

May 4, 2026 8:04 AM

Piper Sandler analyst Yasmeen Rahimi lowered the price target on AnaptysBio (NASDAQ: ANAB) to $93.00 (from $95.00) while maintaining a Overweight rating.

No results found